Syndrome and Aspiration Pneumonia in Intensive Care (SPIRE)

August 25, 2016 updated by: Centre Hospitalier Departemental Vendee

Inhalation is a common condition in patients with impaired their awareness requiring protection of the upper airway by endotracheal intubation. This inhalation may lead to chemical pneumonitis and/or bacterial pneumonia. Only the latter requires the administration of antibiotics. Patients developing such a bacterial pneumonia, has a mortality, duration of mechanical ventilation and length of ICU stay increased. However, the proportion of patients with such bacterial pneumonia, bacterial ecology and morbidity that are little known.

The aim of this study is to determine the frequency of bacterial pneumonia in patients admitted to the ICU for coma and treated with mechanical ventilation

Study Overview

Study Type

Observational

Enrollment (Anticipated)

250

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • La Roche Sur Yon, France, 85000
        • CHD Vendee

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients hospitalized in ICU for coma (define by Glasgow score < 8) and under mechanical ventilation. Suspicion of bacterial inhalation pneumonia will be confirme by a protected distal sampling during a flexible bronchoscopy.

Description

Inclusion Criteria:

  • Altered consciousness defined by a Glasgow Coma Scale score less than or equal to 8 before protection of the upper airway by endotracheal intubation
  • Patient under mechanical ventilation

Exclusion Criteria:

  • Patient with pre-existing impairment of laryngeal function in Parkinson's disease, Alzheimer's disease, amyotrophic lateral sclerosis, laryngeal cancer, radiotherapy laryngeal
  • Patient under guardianship
  • Inpatient without consent
  • Pregnant woman
  • Patient previously treated with antibiotics for more than 24 hours at the time of ICU admission
  • Patient with infection at ICU admission which justified probabilist antibiotic treatment
  • Lack of social security
  • Refusal of the patient or their next of kind

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Coma patients in ICU under mechanical ventilation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Determine the frequency of bacterial pneumonia in patients admitted to the ICU for coma and treated with mechanical ventilation
Time Frame: ICU Discharge
Participants will be followed for the duration of ICU stay, an expected average of 4 days
ICU Discharge

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quantify the use of antibiotics during the ICU stay for patients admitted to the ICU for coma and treated with mechanical ventilation
Time Frame: ICU Discharge
Participants will be followed for the duration of ICU stay, an expected average of 4 days
ICU Discharge
Description of the bacterial flora identified in respiratory specimens.
Time Frame: ICU Discharge
Participants will be followed for the duration of ICU stay, an expected average of 4 days
ICU Discharge
Identification of predictive factors for development of bacterial pneumonia
Time Frame: ICU Discharge
Participants will be followed for the duration of ICU stay, an expected average of 4 days
ICU Discharge

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2012

Primary Completion (Actual)

March 1, 2015

Study Completion (Actual)

April 1, 2015

Study Registration Dates

First Submitted

June 13, 2013

First Submitted That Met QC Criteria

June 17, 2013

First Posted (Estimate)

June 20, 2013

Study Record Updates

Last Update Posted (Estimate)

August 26, 2016

Last Update Submitted That Met QC Criteria

August 25, 2016

Last Verified

August 1, 2016

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on ICU Patients

Subscribe